Eton Pharmaceuticals, Inc. ETON Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Eton Pharmaceuticals, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s common stock issuance for private placement?
- Eton Pharmaceuticals, Inc. (ETON) reported common stock issuance for private placement of $0 in Q4 2025.
- How has Eton Pharmaceuticals, Inc.'s common stock issuance for private placement changed year-over-year?
- Eton Pharmaceuticals, Inc.'s common stock issuance for private placement decreased by 100.0% year-over-year, from $1.75M to $0.
- What does common stock issuance for private placement mean?
- Represents the cash inflow generated from the sale of equity securities directly to private investors rather than through public markets. This activity is a primary source of capital for growth or operational funding without the immediate burden of debt repayment. It serves as an indicator of the company's ability to attract institutional or strategic investment.